Dr Kerryn A Moore
Research Fellow - Malaria & Infectious Diseases Ep
Melbourne School of Population and Global Health
50 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
The Malaria Vaccine Programme Evaluation in Kenya: results of a baseline household survey prior to the introduction of the RTS,S/AS01 vaccine
DOI: 10.1186/s12936-026-05911-22026
Journal article
The Malaria Vaccine Implementation Programme study area in Ghana: results of a household survey prior to the introduction of the RTS,S/AS01 vaccine
DOI: 10.1186/s12936-025-05778-92026
Journal article
Corrigendum to “The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose” [J Infect 90 (2025)/106447]
DOI: 10.1016/j.jinf.2026.1068502026
Journal article
Corrigendum to ‘Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in Australia’ [J Infect 92 (2026)/106727]
DOI: 10.1016/j.jinf.2026.1068512026
Journal article
Impact of introducing RTS,S/AS01E malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme
DOI: 10.1016/S0140-6736(26)00248-52026
Journal article
Reduction of stillbirth rate in refugee and migrant populations living on the Thailand Myanmar border: A retrospective study 1986–2023
DOI: 10.1371/journal.pgph.00059832024
Research grants (ARC, NHMRC, MRFF)
Epidemiological Evidence to Inform Policy on Optimal and Equitable Access to Pneumococcal Vaccination in the Asia-Pacific Region
RECENT SCHOLARLY WORKS
2026
Journal article
Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in Australia
DOI: 10.1016/j.jinf.2026.1067272026
Journal article
Estimating the population direct effect in cluster randomized trials of targeted interventions using contemporaneous counts in a non-target group
DOI: 10.1093/ajeadv/uuag0302026
Journal article
Fractional BNT162b2 boosters induce durable immune responses after non-mRNA priming in Mongolia: a randomised controlled trial
DOI: 10.3389/fimmu.2026.17892482026
Journal article
Cellular immune responses 12 months after fractional or standard dose BNT162b2 booster vaccination in Mongolian adults
DOI: 10.3389/fimmu.2026.1779435